NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/05/2025
Back to search
Official data from USPTO
ARRIVENT
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
09/05/2025
Trademark type
Word
Nice classes
5, 42
Filing date
10/18/2023
Registration date
08/05/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/05/2025
Last transaction
09/05/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
11/14/2024
First use in commerce
11/14/2024
Drawing code
4
Owner type
03
Owner location
Newtown Square, PA
Examiner
JONES, JACQUELYN
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
ArriVent BioPharma, Inc.
Representatives
Wade Savoy PATENT GC LLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of lung cancer
Class 42
research and development in the pharmaceutical and biotechnology fields
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/05/2025
ETOP
EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
07/10/2025
ETOF
EXTENSION OF TIME TO OPPOSE RECEIVED
01/30/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/31/2024
PUBO
PUBLISHED FOR OPPOSITION
12/31/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/25/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/05/2024
IUAA
USE AMENDMENT ACCEPTED
12/05/2024
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
12/04/2024
IUAF
USE AMENDMENT FILED
12/04/2024
EAAU
TEAS AMENDMENT OF USE RECEIVED
12/04/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/04/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/04/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/04/2024
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
07/15/2024
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
07/15/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/10/2024
GNRT
NON-FINAL ACTION E-MAILED
06/10/2024
CNRT
NON-FINAL ACTION WRITTEN
06/10/2024
DOCK
ASSIGNED TO EXAMINER
06/04/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/24/2023
NWAP
NEW APPLICATION ENTERED
10/21/2023
Continuous trademark protection
Get notified about every new filing that threatens ARRIVENT or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.